Skip to main content

High versus standard-protein provision and muscle loss in critically ill patients assessed by muscle ultrasound: A prospective ancillary study of a randomised controlled trial

In brief

Higher-protein feeding did not reduce muscle loss in ventilated ICU patients

In this single-center study of 141 mechanically ventilated patients, thigh muscle area fell over time with both standard and higher-protein feeding. The overall loss did not differ significantly between patients receiving 2.0 versus 1.3 grams of protein per kilogram daily, so whether higher protein improves muscle preservation remains unproven.

Journal
Clinical nutrition (Edinburgh, Scotland) (Q1)
Published
13 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Lara Schepers, Julia L M Bels, Michelle C Paulus, Rob van Gassel, Steven Thiessen, Aude de Watteville, et al.
PMID
43056780
DOI
10.1016/j.clnu.2026.106848

Why clinicians should know about it

Abstract

BACKGROUND & AIMS: Rapid skeletal muscle loss, a hallmark of critical illness, has been linked to delayed recovery, prolonged mechanical ventilation, and reduced quality of life. It has been suggested that increased enteral protein delivery may attenuate this muscle loss in critically ill patients. In this study, we examined the effect of high versus standard enteral protein provision on changes in M. rectus femoris cross-sectional area (RFCSA) in mechanically ventilated critically ill patients. METHODS: We performed a prospective, pre-planned, single-centre ancillary study at Maastricht University Medical Centre, embedded within the quadruple-blinded randomised PRECISe trial, which evaluated the effect of standard (1.3 g/kg/day) versus high (2.0 g/kg/day) protein provision on functional recovery in critically ill patients. We included all patients who had baseline (<2 days after randomisation) and at least one follow-up ultrasound measurement of the M. rectus femoris. The primary outcome for this study was the change in RFCSA, measured during ICU stay and up to 30 days after randomisation. RESULTS: A total of 141 participants were included in this analysis (standard-protein group, n=75; high-protein group, n=66). RFCSA decreased over time in both groups, with a mean daily decrease of 0.077 ± 0.065 cm2 (95% CI, -0.10 to -0.05; p < 0.01) and -0.048 ± 0.047 cm2 (95% CI, -0.07 to -0.02; p < 0.01) in patients allocated to the standard- and high-protein groups, respectively. However, the overall change in RFCSA did not differ between groups (mean difference -0.098 cm2; 95% CI -0.24 to 0.044; p = 0.17). CONCLUSIONS: In mechanically ventilated critically ill patients, high enteral protein provision compared with standard enteral protein provision did not attenuate skeletal muscle loss, as assessed by ultrasound-derived RFCSA. TRIAL REGISTRATION: The PRECISe trial was registered at ClinicalTrials.gov (NCT04633421; https://clinicaltrials.gov/ct2/show/NCT04633421) on 23 October 2020.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.